Answers are grounded in this paper and cite their sources.
Traumatic heterotopic ossification is a pathological condition characterized by the abnormal formation of mature bone in soft tissues following trauma, burns, or surgical interventions. This condition can lead to functional impairment, pain, and a decreased quality of life for patients. Heterotopic ossification is a form of pathological bone regeneration, and its treatment primarily focuses on inhibiting pathological bone formation. This review synthesizes the latest insights into the pathogenesis, risk factors, and clinical management of traumatic heterotopic ossification, highlighting current gaps in knowledge and proposing directions for future research. Although there has been significant progress in understanding of the pathophysiology of traumatic heterotopic ossification, its underlying mechanisms remain not fully elucidated. These mechanisms involve complex interactions among inflammation, mesenchymal stem cell differentiation, genetic susceptibility, and various signaling pathways. Current treatment strategies primarily emphasize prevention through pharmacological interventions, such as non-steroidal anti-inflammatory drugs and bisphosphonates, while surgical resection is considered for severe cases. Emerging approaches, including targeted molecular therapies, hold promise for more effective and personalized treatment.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: